Does DEFIBROTIDE Cause Incorrect product administration duration? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Incorrect product administration duration have been filed in association with DEFIBROTIDE (DEFITELIO). This represents 0.7% of all adverse event reports for DEFIBROTIDE.
26
Reports of Incorrect product administration duration with DEFIBROTIDE
0.7%
of all DEFIBROTIDE reports
15
Deaths
9
Hospitalizations
How Dangerous Is Incorrect product administration duration From DEFIBROTIDE?
Of the 26 reports, 15 (57.7%) resulted in death, 9 (34.6%) required hospitalization, and 1 (3.8%) were considered life-threatening.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DEFIBROTIDE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does DEFIBROTIDE Cause?
Off label use (1,323)
Venoocclusive disease (576)
Death (463)
Multiple organ dysfunction syndrome (372)
Venoocclusive liver disease (355)
Intentional product use issue (201)
Hypotension (169)
Haemorrhage (156)
Sepsis (143)
Acute graft versus host disease (140)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which DEFIBROTIDE Alternatives Have Lower Incorrect product administration duration Risk?
DEFIBROTIDE vs DEFLAZACORT
DEFIBROTIDE vs DEGARELIX
DEFIBROTIDE vs DELAFLOXACIN MEGLUMINE
DEFIBROTIDE vs DELAMANID
DEFIBROTIDE vs DELANDISTROGENE MOXEPARVOVEC-ROKL